missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ BTLA Recombinant Human Monoclonal Antibody (10A10)
Human Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA560719
This item is not returnable.
View return policy
Description
BTLA Recombinant Monoclonal Antibody for Flow, ELISA
BTLA or B and T-lymphocyte attenuator is a member of the co-inhibitory receptors of the CD28 superfamily. BTLA is a lymphocyte inhibitory receptor which inhibits lymphocytes during immunes responses. BTLA is constitutively expressed on most CD4+ and CD8+ T cells and its expression progressively decreases upon T cell activation. It remains expressed on Th1 cells, but not Th2 cells. BTLA is a unique co-receptor that interacts with the tumor necrosis factor receptor superfamily member herpesvirus entry mediator (HVEM). This interation is an important pathway regulating lymphocyte activation and/or homeostasis in the immune response.
Specifications
| BTLA | |
| Recombinant Monoclonal | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.03% ProClin 300; pH 7.4 | |
| Q7Z6A9 | |
| BTLA | |
| Recombinant Human BTLA protein. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG4 |
| ELISA, Flow Cytometry | |
| 10A10 | |
| Unconjugated | |
| BTLA | |
| A630002H24; B and T lymphocyte associated; B and T lymphocyte associated protein; B and T lymphocyte attenuator; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; BTLA; BTLA_HUMAN; BTLA1; CD272; CD272 antigen; FLJ16065; MGC129743 | |
| Human | |
| Affinity chromatography | |
| RUO | |
| 151888 | |
| -20°C or -80°C if preferred | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction